68Ga FAPI-04 PET/MRI for Detecting Metastatic Bone Lesions of Esophageal Cancer in Patients With G-CSF Administration, Missed by 18F FDG PET/CT
We report a patient who underwent surgery for esophageal cancer, in whom 18 F FDG PET/CT showed diffuse skeletal uptake, while 68 Ga FAPI-04 PET/MRI revealed significantly higher uptake in bone metastatic lesions. Bone lesions were visible after granulocyte-colony stimulating factor(G-CSF) administration due to lower 68 Ga FAPI-04 background uptake, suggesting its superior potential for detecting bone metastases in esophageal cancer patients after G-CSF treatment.
Authors
- Alei Xu
- Hui Wang (ORCID: https://orcid.org/0000-0002-1608-3782)
- Xiaoyu Su (ORCID: https://orcid.org/0000-0002-2472-3591)
- Lei Yao (ORCID: https://orcid.org/0009-0009-2801-8783)
- Jingxuan Miao (ORCID: https://orcid.org/0000-0002-0368-0748)
Institutions
- Anhui Medical University (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
- Lu'an First People's Hospital (CN)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2025-04-24
- DOI
- https://doi.org/10.1097/rlu.0000000000005885
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00